[HLA-restricted cancer-specific killer T cells].
Harada
Mamoru
M
Department of Immunology, Kurume University School of Medicine.
Itoh
Kyogo
K
D017951:Antigen Presentation; D000951:Antigens, Neoplasm / Q000276:immunology; D019496:Cancer Vaccines / Q000627:therapeutic use; D000939:Epitopes; D006680:HLA Antigens; D015395:Histocompatibility Antigens Class I / Q000276:immunology; D006801:Humans; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy; D010455:Peptides / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D019139:Tumor Escape
D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D000939:Epitopes; D006680:HLA Antigens; D015395:Histocompatibility Antigens Class I; D010455:Peptides